Deals· June 12, 2026 · 7 min read
GSK pays $10.6B for Nuvalent: zidesamtinib PDUFA Sept 2026, two NSCLC franchises
By Ran Chen#M&A#Oncology#FDA Approval
Section
Deals
Licensing, acquisitions, partnerships, and alliance terms that change therapeutic-area competition.
2 articles · Last updated
Deals· June 9, 2026 · 6 min read